4.6 Review

PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR β

期刊

PHYSIOLOGICAL REVIEWS
卷 94, 期 3, 页码 795-858

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physrev.00027.2013

关键词

-

资金

  1. Institut National de la Sante et de la Recherche Medicale
  2. University of Nice Sophia Antipolis
  3. Fondation pour la Recherche Medicale (FRM) [DRM20101220437]
  4. Agence Francaise de Lutte contre le Dopage (AFLD)

向作者/读者索取更多资源

The peroxisome proliferator-activated receptors, PPAR alpha, PPAR beta, and PPAR gamma, are a family of transcription factors activated by a diversity of molecules including fatty acids and fatty acid metabolites. PPARs regulate the transcription of a large variety of genes implicated in metabolism, inflammation, proliferation, and differentiation in different cell types. These transcriptional regulations involve both direct transactivation and interaction with other transcriptional regulatory pathways. The functions of PPAR alpha and PPAR gamma have been extensively documented mainly because these isoforms are activated by molecules clinically used as hypolipidemic and antidiabetic compounds. The physiological functions of PPAR beta remained for a while less investigated, but the finding that specific synthetic agonists exert beneficial actions in obese subjects uplifted the studies aimed to elucidate the roles of this PPAR isoform. Intensive work based on pharmacological and genetic approaches and on the use of both in vitro and in vivo models has considerably improved our knowledge on the physiological roles of PPAR beta in various cell types. This review will summarize the accumulated evidence for the implication of PPAR beta in the regulation of development, metabolism, and inflammation in several tissues, including skeletal muscle, heart, skin, and intestine. Some of these findings indicate that pharmacological activation of PPAR beta could be envisioned as a therapeutic option for the correction of metabolic disorders and a variety of inflammatory conditions. However, other experimental data suggesting that activation of PPAR beta could result in serious adverse effects, such as carcinogenesis and psoriasis, raise concerns about the clinical use of potent PPAR beta agonists.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据